Mahip Industries (542503)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Latest quarter shows ₹7 Cr sales and ₹3 Cr net profit, implying an unusually strong margin
• Sales growth of 3,490% and profit growth of 310.26% reflect powerful recent momentum
• Piotroski F-Score of 6/9 suggests some improvement in financial health
• PEG ratio of 0.25 would be attractive if the current growth rate proves durable
• Price is at the bottom of the 52-week range, so market expectations appear low

Concerns

• P/E of 479.75 signals trailing earnings were minuscule despite the latest quarter spike
• ROCE of 0.00% and absence of book value, ROE, and debt-equity data prevent any reliable balance sheet assessment
• No dividend and unavailable promoter holding data raise governance and minority-interest concerns
• Collapse from ₹30 to ₹3.43 within the 52-week range suggests severe market skepticism

AI Analysis

I have always preferred a satisfactory business at a fair price over a wonderful business at a wonderful price, but I have no desire to buy an unseeable business at any price. Mahip Industries operates in packaging, an industry I can understand, but one that rarely offers decades-long pricing power. The figures here are contradictory. The company trades at ₹3.43, near the bottom of its ₹3.43 to ₹30.00 range, with a market cap of just ₹7 crore. That is tiny. The reported P/E of 479.75 tells me trailing earnings were negligible, even though the latest quarter shows sales of ₹7 crore and net profit of ₹3 crore. Sales up 3,490% and profit up 310% sound electrifying, but they prove nothing until I see them repeated. ROCE is 0.00%, no book value, no debt-equity ratio, and no promoter holding percentage is available. Graham would call this a lack of information, not an opportunity. With a Piotroski score of 6 out of 9, the company has some recent signs of health, and the PEG of 0.25 is seductive, but a low PEG built on one quarter's explosive growth can trap value investors. A 43% net margin in packaging is abnormal and likely unsustainable. There is no dividend, and the price has collapsed from ₹30 to ₹3.43. In this situation, the market may be telling us something the income statement is not. I cannot assess moat, management quality, or balance sheet strength. Therefore, this is not an investment; it is a speculation. I would wait for many quarters of consistent profitability and much better disclosure before parting with my money.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer